ATE296096T1 - Erucamid-verbindungen zur behandlung und prävention von störungen des sekretorischen systems - Google Patents

Erucamid-verbindungen zur behandlung und prävention von störungen des sekretorischen systems

Info

Publication number: ATE296096T1
Authority: AT; Austria
Prior art keywords: treatment; disease; erucamide; prevention; compounds
Prior art date: 2001-06-27

Application number

AT02741579T

Other languages

English (en)

Inventor

Anders Hamberger

Gunnar Stenhagen

Original Assignee

Anders Hamberger

Gunnar Stenhagen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-27

Filing date

2002-06-19

Publication date

2005-06-15

2002-06-19 Application filed by Anders Hamberger, Gunnar Stenhagen filed Critical Anders Hamberger

2005-06-15 Application granted granted Critical

2005-06-15 Publication of ATE296096T1 publication Critical patent/ATE296096T1/de

Links

UAUDZVJPLUQNMU-KTKRTIGZSA-N erucamide Chemical class CCCCCCCC\C=C/CCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-KTKRTIGZSA-N 0.000 title abstract 2
230000003248 secreting effect Effects 0.000 title abstract 2
230000002265 prevention Effects 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
201000010099 disease Diseases 0.000 abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
206010012735 Diarrhoea Diseases 0.000 abstract 2
206010048962 Brain oedema Diseases 0.000 abstract 1
206010009900 Colitis ulcerative Diseases 0.000 abstract 1
208000011231 Crohn disease Diseases 0.000 abstract 1
UAUDZVJPLUQNMU-UHFFFAOYSA-N Erucasaeureamid Natural products CCCCCCCCC=CCCCCCCCCCCCC(N)=O UAUDZVJPLUQNMU-UHFFFAOYSA-N 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
206010030113 Oedema Diseases 0.000 abstract 1
201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
208000006752 brain edema Diseases 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
230000007547 defect Effects 0.000 abstract 1
230000006806 disease prevention Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT02741579T 2001-06-27 2002-06-19 Erucamid-verbindungen zur behandlung und prävention von störungen des sekretorischen systems ATE296096T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0102289A SE0102289D0 (sv)	2001-06-27	2001-06-27	New use of compound
PCT/SE2002/001197 WO2003002112A1 (en)	2001-06-27	2002-06-19	Erucamide compounds for the treatment and prevention to disturbances of the secretory system

Publications (1)

Publication Number	Publication Date
ATE296096T1 true ATE296096T1 (de)	2005-06-15

Family

ID=20284639

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02741579T ATE296096T1 (de)	2001-06-27	2002-06-19	Erucamid-verbindungen zur behandlung und prävention von störungen des sekretorischen systems

Country Status (6)

Country	Link
US (1)	US20040192782A1 (de)
EP (1)	EP1408944B1 (de)
AT (1)	ATE296096T1 (de)
DE (1)	DE60204321D1 (de)
SE (1)	SE0102289D0 (de)
WO (1)	WO2003002112A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6631793B2 (en) *	2001-12-13	2003-10-14	Aircraft Braking Systems Corporation	Torque tube and conical back plate for aircraft brake systems
WO2017174557A2 (en) *	2016-04-04	2017-10-12	Brains Online Holding B.V.	Use of push pull microdialysis in combination with shotgun proteomics for analyzing the proteome in extracellular space of brain
CN116725996B (zh) *	2023-05-22	2025-09-12	中鑫群感(上海)生物科技有限公司	一种顺式-11-甲基-2-十二碳烯酸在调节肠道菌群失衡中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4940730A (en) *	1987-10-29	1990-07-10	Takeda Chemical Industries, Ltd.	Angiogenesis enhancer
US5612380A (en) *	1994-09-27	1997-03-18	The Scripps Research Institute	Method for sleep induction
US5952392A (en) *	1996-09-17	1999-09-14	Avanir Pharmaceuticals	Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
CA2273960C (en) *	1996-09-17	2003-12-30	Avanir Pharmaceuticals	Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
DE69833791D1 (de) *	1997-11-24	2006-05-04	Scripps Research Inst	Hemmer der "gap junction communication"
US6858649B1 (en) *	1998-04-30	2005-02-22	The Scripps Research Institute	Selective potentiation of serotonin receptor subtypes
US6365198B1 (en) *	2001-01-28	2002-04-02	Gulf Pharmaceutical Industries	Pharmaceutical preparation for the treatment of gastrointestinal ulcers and hemorrhoids

2001
- 2001-06-27 SE SE0102289A patent/SE0102289D0/xx unknown
2002
- 2002-06-19 EP EP02741579A patent/EP1408944B1/de not_active Expired - Lifetime
- 2002-06-19 WO PCT/SE2002/001197 patent/WO2003002112A1/en not_active Ceased
- 2002-06-19 US US10/482,211 patent/US20040192782A1/en not_active Abandoned
- 2002-06-19 AT AT02741579T patent/ATE296096T1/de not_active IP Right Cessation
- 2002-06-19 DE DE60204321T patent/DE60204321D1/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60204321D1 (de)	2005-06-30
SE0102289D0 (sv)	2001-06-27
EP1408944A1 (de)	2004-04-21
US20040192782A1 (en)	2004-09-30
WO2003002112A1 (en)	2003-01-09
EP1408944B1 (de)	2005-05-25

Similar Documents

Publication	Publication Date	Title
MA25809A1 (fr)	2003-07-01	Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
MA26718A1 (fr)	2004-12-20	Derives de quinoleine-2-one a substituant heteroaryle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN97198A1 (fr)	2005-03-15	Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant
MA26697A1 (fr)	2004-12-20	Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant
DE69411424D1 (de)	1998-08-13	Zur Behandlung von Erkrankungen des Zentralnervensystems verwendbare Benzimidazole
TNSN98203A1 (fr)	2005-03-15	Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
HUP9802678A2 (hu)	1999-02-01	Biciklusos aminszármazékok és ezeket tartalmazó PGD2 antagonista hatású készítmények
MA29335B1 (fr)	2008-03-03	Derives de n-(n-sulfonylaminomethyl) cyclopropanecarboxamide utiles pour le traitement de la douleur
YU84603A (sh)	2006-03-03	Novi inhibitori tirozin kinaze
MXPA04000328A (es)	2004-07-23	Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
MXPA05011150A (es)	2005-12-14	2-hidroxi-3-diaminoalcanos de benzamida.
ATE337316T1 (de)	2006-09-15	Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
MXPA04002785A (es)	2004-07-29	Aminas sustituidas para tratamiento de enfermedad de alzheimer.
MEP54608A (en)	2011-05-10	Arylmethylamine derivatives for use as tryptase inhibitors
TW200502221A (en)	2005-01-16	Novel lactams and uses thereof
BR0113389A (pt)	2003-07-29	Compostos que inibem a atividade do fator xa
WO2002100818A3 (en)	2003-09-25	Aminediols as agents for the treatment of alzheimer's disease
ATE363474T1 (de)	2007-06-15	Benzimidazole zur behandlung sexueller fehlfunktionen
YU75803A (sh)	2006-05-25	Nova dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja
DE69933885D1 (de)	2006-12-14	Triphenylbutenderivate zur behandlung von neurologischen störungen
IL159241A0 (en)	2004-06-01	Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
IL178167A0 (en)	2006-12-31	1,3,4-oxadiazol-2-ones as ppar delta modulators
ATE296096T1 (de)	2005-06-15	Erucamid-verbindungen zur behandlung und prävention von störungen des sekretorischen systems
HUP0301594A2 (hu)	2003-08-28	E-metanikotin diacilborkősav sóját tartalmazó gyógyászati készítmények és alkalmazásuk a központi idegrendszer rendellenességeinek kezelésére
DE69315836D1 (de)	1998-01-29	Pyrazolpyridine für die behandlung der anämie

Legal Events

Date	Code	Title	Description
2005-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties